Correction: Induction of phenotypic changes in HER2-postive breast cancer cells  in vivo  and  in vitro

Anastasia Frank-Kamenetskii; Julia Mook; Meredith Reeves; Corinne A. Boulanger; Thomas J. Meyer; Lauren Ragle; H. Caroline Jordan; Gilbert H. Smith; Brian W. Booth

doi:10.18632/oncotarget.28520

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: Induction of phenotypic changes in HER2-postive breast cancer cells in vivo and in vitro

PDF | How to cite

Oncotarget. 2023; 14:842-842. https://doi.org/10.18632/oncotarget.28520

Metrics: PDF 359 views | ?

Anastasia Frank-Kamenetskii¹, Julia Mook², Meredith Reeves¹, Corinne A. Boulanger³, Thomas J. Meyer^4,5, Lauren Ragle³, H. Caroline Jordan¹, Gilbert H. Smith^3,* and Brian W. Booth^1,*

¹Department of Bioengineering, Clemson University, Clemson, SC, USA
²Department of Biological Sciences, Clemson University, Clemson, SC, USA
³Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
⁴CCR Collaborative Bioinformatics Resource, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
⁵Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, USA
^*These authors contributed equally to this work

Published: September 28, 2023

Copyright: © 2023 Frank-Kamenetskii et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has been corrected: In Figure 2, panels A and B contain accidental ‘placeholder’ images that contain partial duplications of panels E and G. The corrected figure 2, obtained using the original data, shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2020; 11:2919–2929. DOI: https://doi.org/10.18632/oncotarget.27679

Figure 2: Transplantation results following in vitro redirection. (A, B) H&E staining of mammary outgrowth following MEC transplantation. (C) H&E staining of mammary tumor that formed following transplantation of SkBr3-RFP cells. (D) Fluorescent image of C. (E) H&E staining of mammary outgrowth and mammary tumor following transplantation of HER2+ 1:1 fraction. (F) Fluorescent image of E. (G) H&E staining of HER2 + 1:50 fraction. (H) Fluorescent image of outlined area in G. (I) Transplantation results. (J) Survival curve of animals listed in I. Scale bars A, B, E, F, G = 200 μm, C, D, H = 400 μm.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28520

Publication Alerts

Corrections:

Correction: Induction of phenotypic changes in HER2-postive breast cancer cells in vivo and in vitro